立方体的囊泡式方法,其组成部分,制备技术,评估和评估以向癌细胞
Sehrish Iqbal1, Muhammad Zaman1, Muhammad Ahsan Waqar1
1Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, Pakistan.
Journal of liposome research
|October 24, 2023
概括
立方体体是一种新型纳米载体,通过封装药物以提供向的药物来改善癌症治疗. 这些立方脂纳米颗粒增强药物的疗效,减少各种癌症的副作用.
科学领域:
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 化疗会对健康组织造成不良影响,原因是药物分发不受控制.
- 正在探索纳米载体,以提高癌症治疗效率和减少副作用.
- 立方体,一种纳米载体,最近因其独特的特性而引起了人们的注意.
研究的目的:
- 审查用于癌症治疗的立方体的进展.
- 详细阐述囊泡式方法,组成和立方体的制备.
- 讨论瘤学中的立方体体的表征和各种应用.
主要方法:
- 立方体体是使用上下或水流体方法制备的.
- 描述涉及诸如极化光显微镜,光子相关谱,X射线散射 (SAXS) 和传输电子显微镜等技术.
- 稳定性研究对于评估立方体体配方至关重要.
主要成果:
- 立方体体表现出稳定的立方体结构,使药物解离速度更慢,并增加保留.
- 它们表明皮肤癌的药物透率提高,肝癌的生物可用性提高.
- 在立方体中封装的康尼利亚桃提取物显示出结直肠癌治疗的潜力,防止消化道的破坏.
结论:
- 立方体体是一种有前途的纳米载体系统,可用于有效的癌症治疗.
- 它们独特的结构促进了特定地点的药物输送,提高了治疗结果.
- 对立方体的进一步研究可以导致更有针对性,更少有毒的癌症治疗方法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K


